Nearly 200-year-old tortoise provides extraordinary epigenetic clues to human longevity

Key Takeaways

  • Scientists mapped the epigenome of Jonathan, a 194-year-old giant tortoise, identifying 287 gene variants linked to cellular resilience.

  • The study found that the genetic switches controlling Jonathan's DNA repair and metabolism remain remarkably similar to those of young tortoises.

  • Researchers aim to use these evolutionary blueprints to develop practical and affordable treatments for age-related chronic diseases in humans.

Unlocking the secrets of aging through a giant tortoise

At an astonishing estimated age of 194, an Aldabra giant tortoise named Jonathan is not just making history for his longevity, but for his groundbreaking contribution to science. Believed to be the world’s oldest living land animal, Jonathan is now helping researchers understand the profound mysteries of healthy aging.

In a recent study published in the journal Science Advances, scientists mapped the epigenome of a giant tortoise for the first time. Their findings pinpointed 287 unique gene variants in Jonathan that actively combat the typical physical decline associated with aging. These specific variants are responsible for repairing DNA damage, reducing inflammation, regulating insulin, and even suppressing cancer.

When researchers compared Jonathan’s epigenome to those of much younger giant tortoises, the results were extraordinary. The genetic switches controlling Jonathan’s metabolism and DNA repair were practically identical to his younger counterparts, demonstrating an incredible resilience against the genetic wear and tear that usually accompanies a long life.

Dr. Justin Gerlach, a Cambridge University scientist involved in the research, noted that the gene regulators responsible for Jonathan’s energy production have remained incredibly stable over nearly two centuries. “Nature has already solved the puzzle of aging in remarkable ways, and Jonathan’s genome provides a blueprint for cellular resilience,” explained Dr. Stephen Clark, the senior author of the study and founder of the longevity research non-profit Kallel.

The ultimate goal of this research is to translate these fascinating evolutionary insights into practical, affordable medical treatments. By understanding how this magnificent creature has thrived since the 1830s, scientists hope to democratize longevity medicine and significantly reduce the risk of chronic age-related diseases in humans.

Positive Tonic Editorial Team
Positive Tonic Editorial Teamhttp://positivetonic.com
The Positive Tonic Editorial Team publishes stories about science, society, the environment, animals and positive developments. This account identifies the publication editorial team.

Related Articles

Latest Articles